# Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)

> **NCT05144633** · — · RECRUITING · sponsor: **University of Louisville** · enrollment: 100 (estimated)

## Conditions studied

- Acute Respiratory Failure

## Interventions

- **DEVICE:** Auscultation

## Key facts

- **NCT ID:** NCT05144633
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-09
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05144633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05144633, "Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05144633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*